I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

As one of the most commonly seen gynecologic malignant tumors, cervical cancer is showing a growing tendency of incidence and medical cost in recent years.\[[@ref1]\] The treatment of cervical cancer is mainly based on surgeries combined with radiotherapy and chemotherapy that usually takes a long period of time, and the costs of therapies are growing year on year. As one of the medical insurance coverage disease types, its long therapeutic cycle and high treatment costs are bringing severe financial pressures to the patients and medical insurance institutions that have gradually arouse the attention of health administrative departments. The reasonable cost control of inpatient medical expenditures for cervical cancer is crucial in easing the economic burden of patients and medical insurance reimbursements.\[[@ref2]\] Extensive studies showed that among varied factors that affect the hospitalization expenses, payment modes can be counted as one of the most important aspects since medical insurances may compensate a great proportion of medical costs that are likely to increase the possibility of overtreatment despite the fact in reducing the financial burden of patients.\[[@ref3]\]

As a type of sophisticated statistical model, gamma distribution has been widely applied in cost analysis in recent years due to its universal characteristics in the research of health economics.\[[@ref4]\] It is believed that logarithmic linked Gamma model is more suitable for cost analysis since the estimated values are closer to the actual value in compare with multiple linear regression method according to relevant researches. In view of the skewed distribution of the cost, the Gamma model is able to process the data with log linked gamma distribution to ensure the integrity of original information and avoid conversion bias.\[[@ref5]\] However, extensive studies of medical cost analysis using Gamma model are still rare. This paper chose the inpatient cervical cancer cases within a Grade A tertiary hospital of the year 2011--2016 as research samples to verify the application of Gamma model in medical cost analyses. Furthermore, it is hoped that the study of different medical payment modes toward hospitalization expenses can provide solid basis and rational suggestions of cost control for hospitals as well as health administrative and medical insurance departments.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Acquisition and reduction of data and materials {#sec2-1}
-----------------------------------------------

The data and information of patients whose main diagnoses are labeled as cervical cancer from January 1, 2011, to December 31, 2016, within a Grade A tertiary hospital of Beijing were collected through the medical record management system. The data and materials collected included the general situation of the patients (such as age, gender, operations, payment modes, length of hospital stays, admission conditions, treatments, and follow-up situations) and medical costs information including total costs, bed charges, drug costs, treatment costs, examination costs, and other costs.\[[@ref6]\] In regards of eliminating the impact of price fluctuation toward the study to realize the comparability of time span,\[[@ref7]\] the costs of hospitalization were adjusted according to consumer price index in the "China statistical yearbook -- Category of health" of the year 2011--2016, with 2016 as the base year \[[Table 1](#T1){ref-type="table"}\].

###### 

Adjustment of medical cost according to CPI of 2011--2016

  Years   CPI     Medical costs before the adjustment   Medical costs after the adjustment
  ------- ------- ------------------------------------- --------------------------------------------------
  2016    1.020   Y1                                    Y1' = Y1
  2015    1.013   Y2                                    Y2' = Y2 × 1.020
  2014    1.013   Y3                                    Y3' = Y3 × 1.020 × 1.013
  2013    1.020   Y4                                    Y4' = Y4 × 1.020 × 1.013 × 1.013
  2012    1.034   Y5                                    Y5' = Y5 × 1.020 × 1.013 × 1.013 × 1.020
  2011    1.032   Y6                                    Y6' = Y6 × 1.020 × 1.013 × 1.013 × 1.020 × 1.034

CPI: Consumer price index.

Statistical analysis {#sec2-2}
--------------------

The basic information of patients was examined through Kolmogorov-Smirnov normality test.\[[@ref8]\] Since age, length of hospital stay, and medical costs were not subject to normal distribution, median numbers were adopted in the description, while percentages were adopted to indicate the constitution of each cost item toward the total, and a relative number was used in describing categorical variables.\[[@ref9]\] Meanwhile, Chi-square test was used to analyze the difference between the basic information of medical insured and uninsured patients. Setting each medical cost item as dependent variables and set age, marriage status, payment modes, therapeutic options, surgical treatments, pathological type, lymphatic metastasis, as well as distant metastasis and recurrence of the patients as independent variables to construct the logarithmic linked Gamma model.\[[@ref10]\] Analyze the variance of inpatient medical expenditures of patients with and without medical insurance as well as the influencing factors of hospitalization expenses. Meanwhile, marginal costs of medical insured patients and uninsured patients were estimated in the study.\[[@ref11]\] All the data and material collected were entered into Excel 2010 software for Microsoft (Microsoft Corporation, Washington, USA), and statistical analyses were performed using SPSS software version 21.0 (SPSS Inc., Chicago, IL, USA).

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

General situations {#sec2-3}
------------------

A total of 1321 cases of cervical cancer were enrolled in this study, among which 65.9% were medical insured patients and 34.1% were uninsured patients. The median length of hospital stay was 10.5 days and the median age of the enrolled cases was 49.3 years, and 79.9% of patients were performed with surgeries. The general situations of medical insured patients and uninsured patients were shown in [Table 2](#T2){ref-type="table"}, in which the marital status and treatment options were statistically significant, while other factors showed no significant difference between the two groups.

###### 

Basic information of medical insured and uninsured patients (*n* (%))

  Variables                                                Insured patients (*n* = 871)   Uninsured patients (*n* = 450)   *χ*^2^   *P*
  -------------------------------------------------------- ------------------------------ -------------------------------- -------- -------
  Age                                                                                                                               
   ≤20 years                                               25 (2.8)                       16 (3.6)                         4.002    0.258
   21--30 years                                            51 (5.8)                       35 (7.7)                                  
   31--40 years                                            121 (13.9)                     68 (15.1)                                 
   41--50 years                                            321 (36.9)                     178 (39.6)                                
   51--60 years                                            221 (25.4)                     109 (24.2)                                
   ≥61 years                                               132 (15.2)                     44 (9.8)                                  
  Hospital stay                                                                                                                     
   1--10 days                                              350 (40.2)                     213 (47.3)                       6.852    0.079
   11--20 days                                             273 (31.3)                     133 (29.6)                                
   21--30 days                                             131 (15.1)                     74 (16.4)                                 
   ≥30 days                                                117 (13.4)                     30 (6.7)                                  
  Marriage status                                                                                                                   
   Married                                                 795 (91.3)                     427 (94.9)                       5.118    0.037
   Unmarried                                               76 (8.7)                       23 (5.1)                                  
  Surgical treatments                                                                                                               
   Yes                                                     717 (82.3)                     339 (75.3)                       1.721    0.203
   No                                                      154 (17.7)                     111 (24.7)                                
  Therapeutic options                                                                                                               
   Surgery                                                 144 (16.5)                     106 (23.6)                       11.975   0.029
   Surgery in combine with chemotherapy or radiotherapy    395 (45.4)                     189 (42)                                  
   Surgery in combine with chemotherapy and radiotherapy   122 (14)                       46 (10.2)                                 
   Chemotherapy or radiotherapy                            113 (13)                       54 (12)                                   
   Chemotherapy and radiotherapy                           54 (6.2)                       26 (5.8)                                  
   Others                                                  43 (4.9)                       29 (6.4)                                  
  Pathological type                                                                                                                 
   Squamous cell carcinoma                                 707 (81.2)                     370 (82.2)                       4.014    0.249
   Adenocarcinoma                                          109 (12.5)                     53 (11.8)                                 
   Adenosquamous carcinoma                                 37 (4.2)                       17 (3.8)                                  
   Others                                                  18 (2.1)                       10 (2.2)                                  
  Lymphatic metastasis                                                                                                              
   Yes                                                     448 (51.4)                     264 (58.7)                       2.513    0.121
   No                                                      423 (48.6)                     186 (41.3)                                
  Distant metastasis and recurrence                                                                                                 
   Yes                                                     285 (32.7)                     169 (37.6)                       0.101    0.746
   No                                                      586 (67.3)                     281 (62.4)                                

Inpatient medical expenditure of insured and uninsured patients {#sec2-4}
---------------------------------------------------------------

In the study, the inpatient medical expenditures of medical insured and uninsured patients were RMB 29,509.1 Yuan and RMB 22,114.3 Yuan, respectively. Of the specifics, drug costs, surgery costs as well as treatment costs were the top three cost categories, with drug costs accounted for 37.7% and 33.8% of the total costs, surgery costs accounted for accounted for 21.5% and 25.5%, treatment costs accounted for 18.7% and 16.4%, whereas the costs of imaging and laboratory examinations accounted for 16.4% and 15.2% among insured and uninsured patients, respectively, as shown in [Table 3](#T3){ref-type="table"}.

###### 

Hospitalization expenses and constitutions of medical insured and uninsured patients

  Cost items                                 Insured patients   Uninsured patients              
  ------------------------------------------ ------------------ -------------------- ---------- ------
  Treatment costs                            5518.1             18.7                 3626.7     16.4
  Drug costs                                 9649.5             32.7                 6811.2     30.8
  Imaging and laboratory examination costs   4839.5             16.4                 3361.4     15.2
  Surgery costs                              6344.5             21.5                 5639.1     25.5
  Other costs                                324.6              1.1                  398.1      1.8
  Bed charges                                1298.4             4.4                  906.7      4.1
  Nursing costs                              1534.5             5.2                  1371.1     6.2
                                                                                                
  Total costs                                29,509.1           100                  22,114.3   100

Influence of payment modes toward inpatient medical expenditures of cervical cancer patients {#sec2-5}
--------------------------------------------------------------------------------------------

The results of Gamma analysis between different payment modes toward the inpatient medical expenditures of cervical cancer were shown in [Table 4](#T4){ref-type="table"}; as payment modes, therapeutic options as well as the recurrence and metastasis of tumor were counted as statistically significant. Further analyses on medical costs of the insured and uninsured inpatient costs as we regulated the covariates were shown in [Table 5](#T5){ref-type="table"}, while total costs, drug costs, treatment costs as well as examination costs were significantly different between medical insured and uninsured patients, as the total hospitalization costs, drug costs, treatment costs, and examination costs of insured inpatient were 1.33, 1.42, 1.52, and 1.44 times of uninsured patients, respectively.

###### 

Multivariate analysis of the influencing factors of hospitalization expenses in cervical cancer patients using Gamma model

  Variables                           *χ*^2^   *P*
  ----------------------------------- -------- ---------
  Age                                 0.501    0.793
  Marriage status                     2.823    0.402
  Payment modes                       8.719    0.029
  Therapeutic options                 89.725   \<0.001
  Surgical treatments                 0.251    0.596
  Pathological types                  5.107    0.163
  Lymphatic metastasis                0.897    0.314
  Distant metastasis and recurrence   12.998   \<0.001

###### 

The results of Gamma analysis on different cost items of medical insured and uninsured patients

  Variables                                   Payment modes   Marginal mean value (RMB Yuan)   *χ*^2^   *P*
  ------------------------------------------- --------------- -------------------------------- -------- -------
  Treatment costs                             Insured         9380.3                           12.006   0.019
  Uninsured                                   7514.9                                                    
  Average deviation                           1865.4          --                               0.027    
  Drug costs                                  Insured         4545.0                           4.832    0.031
  Uninsured                                   3925.1                                                    
  Average deviation                           619.9           --                               0.042    
  Imaging and laboratory examinations costs   Insured         8275.5                           9.107    0.028
  Uninsured                                   7047.6                                                    
  Average deviation                           1227.9          --                               0.015    
  Surgery costs                               Insured         8247.9                           5.284    0.113
  Uninsured                                   8118.4                                                    
  Average deviation                           129.5           --                               0.102    
  Other costs                                 Insured         451.2                            2.215    0.136
  Uninsured                                   402.3                                                     
  Average deviation                           48.9            --                               0.164    
  Bed charges                                 Insured         1752.8                           5.791    0.119
  Uninsured                                   1500.8                                                    
  Average deviation                           252.0           --                               0.104    
  Nursing costs                               Insured         2148.3                           2.897    0.139
  Uninsured                                   2002.8                                                    
  Average deviation                           145.5           --                               0.145    
                                                                                                        
  Total costs                                 Insured         20,656.4                         9.198    0.003
  Uninsured                                   17,980.0                                                  
  Average deviation                           2676.14         --                               0.006    

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Influence of payment modes toward total inpatient medical expenditures among cervical cancer patients {#sec2-6}
-----------------------------------------------------------------------------------------------------

As is widely known, payment modes have significant influence toward medical expenditures in clinical. According to the study, marital status and treatment options were statistically significant in inpatient medical expenditures between medical insured patient and uninsured patients.\[[@ref12]\] Notably, marital status is somehow related to the medical insurance type among some patients and that medical insurance status may influence patients\' choices on treatment options.\[[@ref13]\] Thus, to exclude the influence of covariates, Gamma model was adopted to control the other covariates in further analyses, and results showed that the hospitalization expenses among cervical cancer patients with medical insurance were significantly higher than those without, this is in accordance with other domestic and foreign researches.\[[@ref14]\] Here are several possible reasons: first, the proportion of uninsured patients in China is still quite large since the medical insurance coverage is not complete, which may place limits to their medical behavior in a certain degree when seeking medical treatments.\[[@ref15]\] Second, according to relevant studies, different medical payment modes are having certain stimulations and inducements toward doctors in their therapeutic behaviors. This may largely attribute to the self-financing reality of Chinese hospitals since health-care funds in China are seriously insufficient, and that some medical service providers are inclined to provide excessive treatments due to economic-induced demands since it is directly related to the profit of the hospitals and the income of medical staffs.\[[@ref16]\] Last but not least, the diagnosis of cervical cancer was selected as the trial item in the first diagnosis-related groups\' prospective payment system categories in China, which might result to excessive medical services among patients with health-care insurance.\[[@ref17]\]

Influence of therapeutic options as well as recurrence and metastasis of tumor toward total inpatient medical expenditures among cervical cancer patients {#sec2-7}
---------------------------------------------------------------------------------------------------------------------------------------------------------

According to Gamma model analysis, the results of therapeutic options as well as the recurrence and metastasis of tumor toward the inpatient medical expenditures of cervical cancer were statistically significant. In regard to the characteristics of cervical cancer, it was explicable that the medical costs of different therapeutic options vary significantly since a great amount of adjunctive therapies and maintenance therapy (such as chemotherapies, radiotherapy as well as immunotherapies) might be involved in the treatment. While the recurrence and metastasis of tumor reflect the severity of disease, the status of patients, and the difficulty in further treatment, it is obvious that the variance in the indicator has significant differences toward the overall medical costs among cervical cancer patients.

Influence of payment modes toward different medical cost items among cervical cancer patients {#sec2-8}
---------------------------------------------------------------------------------------------

In the research, Gamma model was also applied in analyzing the average medical expenses toward different cost items in the control of other covariates. Moreover, results showed that drug costs, treatment costs, and examination costs of medical insured patients are 1.42, 1.52, and 1.44 times of uninsured patients. On the contrary, since other costs items (such as surgery costs, bed charges as well as nursing costs) are nonnegligible and irreplaceable for the treatment, no significant difference between medical insured and uninsured patients was shown in the study. Furthermore, it is believed that the differences in drug costs will gradually be narrowed between medical insured and uninsured patients, and the gaps of other cost items will be relatively expanded with the implementation of health-care reform policies when the profits of drug makeups were cancelled, and the usage of unnecessary drugs was further cut down by the hospital.\[[@ref18]\]

Application of Gamma model in medical cost analysis {#sec2-9}
---------------------------------------------------

The statistical methods that most frequently used in medical cost analysis including multiple linear models, logistic regression as well as various multivariate statistical analyses.\[[@ref19]\] As for the cost analyses of nonnormal distributions, the most commonly used method is the construction of the multiple linear model by the logarithm transformation of the original data. However, the application of the method calls for strict conditions, and the intercept estimation bias may exist in the predictive values of exponentiation cost estimations.\[[@ref20]\] Logistic regression does not require normal distribution and homogeneity of variance, but the integrity of data information was reduced through the classification of the continuous cost data.\[[@ref21]\] In comparison, the Gamma model processes the data with the log linked gamma distribution with regard to the skewed distribution characteristics of the cost data, ensures the integrity of the original data information, and avoids the conversion bias.\[[@ref22]\] The results of similar studies show that the Gamma model is more suitable for a medical cost analysis by comparing the results of multiple linear regressions and the logarithmic link Gamma model since the estimated average cost values through Gamma model are closer to the actual value.\[[@ref23]\] Thus, the analysis of medical expenditures based on Gamma model could be applied to other similar single diseases such as uterine benign diseases, normal deliveries, and other common diagnoses of gynecology.

Since the study was based on a single-centered hospital, considering the differences in economic level, medical insurance policies as well as epidemiology of the disease, the generalization of the results should be more careful in other regions and circumstances.
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